FDA product code QJS: Interoperable Automated Glycemic Controller, Insulin Suspend

QJS is the FDA product code for interoperable automated glycemic controller, insulin suspend. It is a Class II device, regulated under 21 CFR 862.1356 and reviewed by the Clinical Chemistry panel. FDA has cleared 1 510(k) submission under QJS. The average 510(k) review took 73 days (median 73).

Definition

An interoperable automated glycemic controller, insulin suspend, is a device that temporarily suspend and resumes insulin infusion from a connected infusion pump based on specified thresholds and input glucose levels. Interoperable automated glycemic controllers, insulin suspend, are designed to reliably and securely communicate with digitally connected devices to allow insulin delivery suspension and resumption commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers, insulin suspend, are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Classification

FieldValue
Device nameInteroperable Automated Glycemic Controller, Insulin Suspend
Device classClass II
Regulation21 CFR 862.1356
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for QJS

YearClearancesAvg. review days
2020173

Compare with all 510(k) review times · Search every QJS clearance

Top QJS applicants

ApplicantClearancesLatest
Tandem Diabetes Care, Inc.12020-02-28

Most recent QJS clearances

510(k)ApplicantDeviceDecision dateReview days
K193483Tandem Diabetes Care, Inc.Basal-IQ Technology2020-02-2873

Recalls for QJS devices

FDA recall records list no recalls for product code QJS.

Frequently asked questions

What is FDA product code QJS?

QJS is the FDA product code for interoperable automated glycemic controller, insulin suspend. It is a Class II device, regulated under 21 CFR 862.1356 and reviewed by the Clinical Chemistry panel.

What device class is QJS?

Class II, regulation 21 CFR 862.1356. Typical premarket route: 510(k).

How long does a 510(k) take for product code QJS?

Across 1 cleared submissions the average was 73 days from receipt to decision (median 73).

Which companies have the most QJS clearances?

Tandem Diabetes Care, Inc. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times